The company is a pioneer in selecting, breeding and marketing pigs for biomedical research and is held by Bioemprèn, Semen Cardona and the IRTA. Specipig is currently breeding conventional pigs with a high standard of health for biomedical research centres, hospitals, pharmaceutical companies and medical device firms. However, the company has also launched a genetic-selection programme aimed at creating its own line of minipigs under the brand Specipig®. This new line is being developed with the IRTA, through researchers in the Animal Breeding and Genetics programme.